We have renewed our partnership with Cancer Research UK (CRUK)’s drug discovery engine, Cancer Research Horizons, for the world-leading Functional Genomics Centre (FGC). FGC is a centre of excellence in genetic screening, cancer models, CRISPR vector design and computational approaches to big data. Learn more about how we’re working with Cancer Research Horizon’s to solve some of the most important problems in cancer today: https://learn.az/6044mfMV6
AstraZeneca
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 2,976,911 followers
About us
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
- Website
-
http://www.astrazeneca.com
External link for AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business
Locations
-
Primary
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA, GB
-
Astraallen
Sodertalje, Stockholm County 152 57, SE
Employees at AstraZeneca
Updates
-
We're playing our part to deliver better healthcare outcomes with a lower environmental footprint. By harnessing the power of sustainable science, and in partnership with ERM, we’re decarbonising our clinical trials and accelerating progress towards net zero healthcare. 🌍 Learn more: https://learn.az/6045m4Pzl #WhatScienceCanDo
-
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia, accounting for a third of all cases, globally. We support the important role the CLL Advocates Network and every member of the CLL community play as we work together to level up and increase health equity for patients. Learn more: https://learn.az/6048m0noG #WCLLD24 #LetsLevelUp
-
Transthyretin-mediated amyloid cardiomyopathy can be an underlying cause of heart failure with preserved ejection-fraction and can be fatal if left untreated. We will gather with cardiologists at the European Society of Cardiology Congress 2024 to explore how earlier detection and diagnosis of heart failure and identification of risk factors can improve patient outcomes. Martin Cowie examines this need for change in practice alongside the World Heart Federation and a leading heart failure specialist in this article published on STAT: https://learn.az/6044mgFvE
-
We’re pursuing ambitious science-based decarbonisation targets, accelerating our progress towards net zero. Our site in Södertälje, Sweden, which is one of the largest medicines manufacturing sites in the world, has reduced its Scope 1 and 2 greenhouse gas emissions by 98% since 2015. This marks a significant milestone in our Ambition Zero Carbon journey. Find out more about our commitment to bold climate action: https://learn.az/6042mbeRO
-
We have been awarded two 2024 Freezer Challenge awards from My Green Lab and the I2SL: International Institute for Sustainable Laboratories, recognising our commitment to sustainable science. These include the Winning Streak Award for Biotech & Pharmaceuticals for exceeding our energy savings from the 2023 Freezer Challenge, and the Top Small Lab Award – Pharmaceutical & Biotech Sector for our Gothenburg Regional HBS Centre. #WhatScienceCanDo
-
Endometrial cancer is the sixth most common cancer in women worldwide, with incidence rates rising. Conversation and education are critical to changing this future. Understanding the symptoms – and challenging each other as a community to raise open and honest awareness – is how we are going to make a difference against this disease. #EndometrialCancer #UterineCancer #WombCancer
-
Our approach to sustainable science is transforming R&D practices to deliver life-changing medicines across the globe. From our state-of-the-art Discovery Centre (DISC) in Cambridge, to our labs in Gothenburg and Gaithersburg, we're driving health innovation with a lower environmental footprint. Our efforts are contributing to a 98% reduction in our Scope 1 and 2 greenhouse gas emissions from a 2015 baseline. Discover how we’re making progress toward our Ambition Zero Carbon targets and building a healthier future for people and the planet https://learn.az/6049lEz1L #WhatScienceCanDo #NetZero
-
Our latest article dives into how cutting-edge tools like generative AI enhance data analysis, fuel clinical trials and bring us a step closer to our ultimate goal - better medicine for patients. Find out more about this exciting journey towards scientific innovation: https://learn.az/6048YCzv2 #GenerativeAI #DataScience